Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic- Associated Fatty Liver Disease (MAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06135467
What this trial is testing

Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease

Who this might be right for
Mafld in Ckd Patients
Assiut University 150
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Very early researchStudy completedNCT04853082
What this trial is testing

Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution

Who this might be right for
Fatty Liver
Hongsheng Tan 57
Not applicableNot Yet RecruitingNCT07085962
What this trial is testing

Efficacy and Safety of Calculus Bovis Sativus in Adults With MAFLD

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
Huazhong University of Science and Technology 40
Post-approval studies (Phase 4)Active Not RecruitingNCT05782972
What this trial is testing

Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study

Who this might be right for
Metabolic Associated Fatty Liver Disease
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 50
Not applicableStudy completedNCT07539584
What this trial is testing

Adiponectin in Patients With Metabolic Disorders

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Type 2 Diabetes Mellitus (T2DM)
Moscow Regional Research and Clinical Institute (MONIKI) 130
Not applicableStudy completedNCT07663682
What this trial is testing

Correlation Between Serum Nociceptin and Sympathetic Nerve Activity in Diabetic Patients With MAFLD

Who this might be right for
Diabetes Mellitus, Type 2Metabolic Associated Fatty Liver Disease
Second Hospital of Shanxi Medical University 100
Not applicableNot Yet RecruitingNCT07336563
What this trial is testing

ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)Metabolic SyndromeObesity & Overweight+2 more
Jarosław Drobnik 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT07679542
What this trial is testing

Dihydroartemisinin for MAFLD

Who this might be right for
MAFLD
The First Affiliated Hospital with Nanjing Medical University 30
Not applicableLooking for participantsNCT07658755
What this trial is testing

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseLiver FibrosisNon-alcoholic Fatty Liver Disease NAFLD+3 more
Hospital General Universitario Gregorio Marañon 3,000
Very early researchLooking for participantsNCT07185932
What this trial is testing

Efficacy and Safety of Rifaximin in Treating MAFLD

Who this might be right for
Metabolic-associated Fatty Liver Disease
Shanghai Changzheng Hospital 40
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Not applicableUnknownNCT05804409
What this trial is testing

Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients

Who this might be right for
Pancreatic Exocrine Insufficiency
Assiut University 70
Not applicableStudy completedNCT05558592
What this trial is testing

Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease)

Who this might be right for
Metabolic DiseaseFatty Liver, Nonalcoholic
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Post-approval studies (Phase 4)UnknownNCT06501326
What this trial is testing

Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseObesity
Affiliated Hospital of Nantong University 102
Not applicableStudy completedNCT06492369
What this trial is testing

MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients

Who this might be right for
Metabolic- Associated Fatty Liver Disease (MAFLD)
Tanta University 382
Not applicableLooking for participantsNCT07632677
What this trial is testing

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated SteatohepatitisMetabolic Dysfunction-associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 10,000
Post-approval studies (Phase 4)Study completedNCT05474560
What this trial is testing

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseHyperuricemia
Ain Shams University 90
Testing effectiveness (Phase 2)UnknownNCT05966025
What this trial is testing

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver DiseaseFatty Liver
October 6 University 60
Not applicableUnknownNCT06180928
What this trial is testing

Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric Surgery

Who this might be right for
Metabolic Associated Fatty Liver DiseaseBariatric Surgery Candidate
Assiut University 50
Next Page